HAROLD J. SIMON, M.D., PH.D.; LOWELL A. RANTZ, M.D., F.A.C.P.
The introduction of penicillin revolutionized the treatment of Gram-positive coccal infections. Mortality from pneumococcal and beta hemolytic streptococcal infections became a rarity. Staphylococcal infections also responded to penicillin therapy with almost uniform regularity initially, but the incidence of penicillin resistant infections began to rise even before 1950. As many as 90 per cent of staphylococcal infections seen in hospital settings were associated with penicillin resistant strains by the mid-1950's (1). Treatment was based on combinations of bacteriostatic drugs or on the use of toxic agents which were difficult to administer (2).
Treatment failures were not always due to antimicrobial resistance
Learn more about subscription options.
Register Now for a free account.
SIMON HJ, RANTZ LA. The Newer Penicillins: II. Clinical Experiences with Methicillin and Oxacillin. Ann Intern Med. 1962;57:344–362. doi: 10.7326/0003-4819-57-3-344
Download citation file:
Published: Ann Intern Med. 1962;57(3):344-362.
Infectious Disease, Rheumatology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only